|Articles|November 1, 2002
Changing of guard: CIBA Vision successor takes reins as CEO retires
Atlanta-Glen Bradley will retire as chief executive officer of CIBA Vision in early 2003 after more than 30 years of service with affiliated Novartis Corp. companies.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
2
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
3
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
4
Managing Unique Dry Eye Disease Subtypes in Patients
5













































.png)


